 CARLSBAD, Calif., Jan. 11, 2021 GLOBE NEWSWIRE -- GenMark Diagnostics, Inc. NASDAQ: GNMK, a leading provider of automated, multiplex molecular diagnostic testing systems, today provided preliminary operational and financial results for the year ended December 31, 2020. 